0001104659-20-075230.txt : 20200619
0001104659-20-075230.hdr.sgml : 20200619
20200619161519
ACCESSION NUMBER: 0001104659-20-075230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200617
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ADAMS THOMAS PHD
CENTRAL INDEX KEY: 0001234366
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 20975796
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Oncology, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Trovagene, Inc.
DATE OF NAME CHANGE: 20130304
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
4
1
a4.xml
4
X0306
4
2020-06-17
0
0001213037
Cardiff Oncology, Inc.
CRDF
0001234366
ADAMS THOMAS PHD
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE AVENUE
SAN DIEGO
CA
92121
1
1
0
0
Executive Chairman
Stock Options
2.60
2020-06-17
4
A
0
173145
0.00
A
2030-06-17
Common Stock
173145
477870
D
57,715 vest on each of June 17, 2021, 2022 and 2023.
/s/ Thomas Adams
2020-06-19